Birchview Capital, LP Voyager Therapeutics, Inc. Transaction History

Birchview Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$7.15 - $12.28 $214,500 - $368,400	-30,000 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$8.0 - $19.66 $24,000 - $58,980	-3,000 Reduced 9.09%	30,000 $574,000
Q1 2018 May 07, 2018	SELL	$16.16 - $31.31 $161,600 - $313,100	-10,000 Reduced 23.26%	33,000 $620,000
Q4 2017 Feb 02, 2018	BUY	$12.26 - $25.88 $232,940 - $491,720	19,000 Added 79.17%	43,000 $714,000
Q3 2017 Nov 02, 2017	BUY	$8.37 - $20.59 $200,879 - $494,160	24,000	24,000 $494,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $207M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.